FULGENT GENETICS, INC. Proceeds from Income Tax Refunds
FULGENT GENETICS, INC. (FLGT) reported Proceeds from Income Tax Refunds of $4.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2026-02-27
- FULGENT GENETICS, INC. proceeds from income tax refunds for the quarter ending 2025-12-31 was $2.80M, a 90.73% decline year-over-year.
- FULGENT GENETICS, INC. proceeds from income tax refunds for the quarter ending 2025-09-30 was $100.00K, a 96.55% decline year-over-year.
- FULGENT GENETICS, INC. proceeds from income tax refunds for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- FULGENT GENETICS, INC. proceeds from income tax refunds for the quarter ending 2025-03-31 was $1.70M, a 72.58% decline year-over-year.
- FULGENT GENETICS, INC. proceeds from income tax refunds for fiscal 2025 was $4.60M, a 88.50% decline from fiscal 2024.
- FULGENT GENETICS, INC. proceeds from income tax refunds for fiscal 2024 was $40.00M, a 220.00% increase from fiscal 2023.
- FULGENT GENETICS, INC. proceeds from income tax refunds for fiscal 2023 was $12.50M, a 4066.67% increase from fiscal 2022.
- FULGENT GENETICS, INC. proceeds from income tax refunds for fiscal 2022 was $300.00K.
| Period end | Proceeds from Income Tax Refunds 3 month | Proceeds from Income Tax Refunds 6 month | Proceeds from Income Tax Refunds 9 month | Proceeds from Income Tax Refunds 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.90M derived: sum of 2 quarters · filed 2026-02-27 | $2.90M derived: sum of 3 quarters · filed 2026-02-27 | $4.60M 10-K · filed 2026-02-27 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-07 | $100.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.80M 10-Q · filed 2025-11-07 | $32.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.70M 10-Q · filed 2025-08-01 | $31.90M derived: sum of 3 quarters · filed 2026-02-27 | $34.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-02 | $31.90M derived: sum of 2 quarters · filed 2026-02-27 | $34.80M derived: sum of 3 quarters · filed 2026-02-27 | $35.50M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $30.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $33.10M derived: sum of 2 quarters · filed 2026-02-27 | $33.80M derived: sum of 3 quarters · filed 2026-02-27 | $40.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.90M 10-Q · filed 2025-11-07 | $3.60M derived: sum of 2 quarters · filed 2025-11-07 | $9.80M 10-Q · filed 2025-11-07 | $21.60M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $700.00K 10-Q · filed 2025-08-01 | $7.00M 10-Q · filed 2025-08-01 | $18.70M derived: sum of 3 quarters · filed 2026-02-27 | $18.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $6.20M 10-Q · filed 2025-05-02 | $18.00M derived: sum of 2 quarters · filed 2026-02-27 | $18.00M derived: sum of 3 quarters · filed 2026-02-27 | $18.04M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.80M derived: sum of 2 quarters · filed 2026-02-27 | $11.84M derived: sum of 3 quarters · filed 2026-02-27 | $12.50M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $43.00K derived: sum of 2 quarters · filed 2024-11-08 | $700.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $700.00K 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $657.00K 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | $300.00K 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |